可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Wang Y,Lau WB,Gao E,et al.Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury[J].Am J Physiol Endocrinol Metab,2010,298(3):E663-E670.
[2]Wang Y,Tao L,Yuan Y,et al.Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action[J].Am J Physiol Endocrinol Metab,2009, 297(2):E384-E391.
[3]Deepa SS,Dong LQ.APPL1:role in adiponectin signaling and beyond[J].Am J Physiol Endocrinol Metab,2009,296(1):E22-E36.
[4]Fang X,Palanivel R,Cresser J,et al.An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart[J].Am J Physiol Endocrinol Metab,2010,299(5):E721-E729.
[5]Feng X,Zhang Y,Xu R,et al. Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages[J].Atherosclerosis,2010,208(2):396-405.
[6]Mao X,Kikani CK,Riojas RA,et al.APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function[J].Nat Cell Biol,2006,8(5):516-523.
[7]Park M,Youn B,Zheng XL,et al.Globular adiponectin,acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis[J].PLoS One,2011, 6(4):e19143.
[8]Gant-Branum RL,Broussard JA,Mahsut A,et al.Identification of Phosphorylation Sites within the Signaling Adaptor APPL1 by Mass Spectrometry[J].J Proteome Res, 2010,9(3):1541-1548.
[9]Tao L,Gao E,Jiao X,et al.Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress[J].Circulation, 2007,115(11):1408-1416.
[10]Tao L,Wang Y,Gao E,et al.Adiponectin:an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction[J].Circ Res,2010,106(2):409-417.
[11]Yuan M,Ohishi M,Wang L,et al.Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients[J].Clin Exp Pharmacol Physiol,2010,37(8):848-851.
[12]Yuan Y,Jiao X,Lau WB,et al.Thioredoxin glycation:A novel posttranslational modification that inhibits its antioxidant and organ protective actions[J].Free Radic Biol Med,2010,49(3):332-338.
[13]Yi W, Sun Y,Gao E,et al.Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms[J].Antioxid Redox Signal,2011, 15(7):1779-1788.
[14]Yin T,Hou R,Liu S,et al.Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury[J].J Mol Cell Cardiol,2010, 49(3):354-361.
[15]Zhou L,Deepa SS,Etzler JC,et al.Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways[J].J Biol Chem,2009,284(33):22426-11435.